ZCCHC17 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.64757096854373E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.08530001547069E-09 |
Normal-vs-Stage2 |
7.44579997657979E-09 |
Normal-vs-Stage3 |
1.24666943435159E-12 |
Normal-vs-Stage4 |
2.87849966085219E-10 |
Stage1-vs-Stage2 |
1.002150E-01 |
Stage1-vs-Stage3 |
6.992900E-04 |
Stage1-vs-Stage4 |
2.961600E-02 |
Stage2-vs-Stage3 |
3.740000E-01 |
Stage2-vs-Stage4 |
8.219000E-01 |
Stage3-vs-Stage4 |
4.610800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.83464354819307E-12 |
Normal-vs-AfricanAmerican |
2.16430000032908E-07 |
Normal-vs-Asian |
9.332300E-02 |
Caucasian-vs-AfricanAmerican |
5.157600E-01 |
Caucasian-vs-Asian |
4.139400E-01 |
AfricanAmerican-vs-Asian |
3.916000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.7319483321171E-12 |
Normal-vs-Female |
4.78939110593046E-12 |
Male-vs-Female |
7.715200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.954500E-04 |
Normal-vs-Age(41-60Yrs) |
1.51039958318222E-10 |
Normal-vs-Age(61-80Yrs) |
2.12485584683009E-12 |
Normal-vs-Age(81-100Yrs) |
1.80421999999014E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.415600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.598800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.969800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.924200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.853000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.957400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.112040E-01 |
Normal-vs-Grade 2 |
1.72640000073443E-08 |
Normal-vs-Grade 3 |
1.66022751102446E-12 |
Normal-vs-Grade 4 |
2.29930519068944E-11 |
Grade 1-vs-Grade 2 |
3.178400E-01 |
Grade 1-vs-Grade 3 |
2.448100E-02 |
Grade 1-vs-Grade 4 |
1.544000E-02 |
Grade 2-vs-Grade 3 |
4.20640000000638E-05 |
Grade 2-vs-Grade 4 |
1.431510E-04 |
Grade 3-vs-Grade 4 |
4.724600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.82579999955068E-07 |
Normal-vs-ccB subtype |
3.02891045578235E-12 |
ccA subtype-vs-ccB subtype |
2.31780000004012E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.20480300683334E-11 |
Normal-vs-N1 |
8.32860000000712E-05 |
N0-vs-N1 |
4.607800E-01 |
|
|